Literature DB >> 24331159

Impact of socioeconomic status on initial clinical presentation to a memory disorders clinic.

Winnie Qian1, Tom A Schweizer1, Corinne E Fischer1.   

Abstract

BACKGROUND: Dementia affects 15% of Canadians 65 and older, and the prevalence is expected to double over the next two decades. Low socioeconomic status (SES) can increase the risk of Alzheimer's disease (AD) and the precursor mild cognitive impairment (MCI), but it is unknown what the relationship of SES is on initial clinical presentation to a memory disorders clinic.
METHODS: Data from 127 AD and 135 MCI patients who presented to our Memory Disorders Clinic from 2004 to 2013 were analyzed retrospectively. We examined the relationship between SES (measured using Hollingshead two-factor index) and (1) diagnosis of either AD or MCI; (2) age when first presented to clinic; (3) objective cognitive tests to indicate clinical severity; and (4) the use of cognitive enhancers, medication for treating mild-to-moderate AD patients.
RESULTS: AD patients had lower SES than MCI patients (p < 0.001, r = 0.232). Lower SES was associated with a greater age at initial time of diagnosis (χ2 = 11.5, p = 0.001). In MCI patients, higher SES individuals outperformed lower SES individuals on the BNA after correcting for the effect of age (p = 0.004). Lower SES was also associated with decreased use of cognitive enhancers in AD patients (p < 0.001, r = 0.842).
CONCLUSION: Individuals with lower SES come into memory clinic later when the disease has progressed to dementia, while higher SES individuals present earlier when the disease is still in its MCI stage. There were more higher SES individuals who presented to our memory clinic. Higher SES is associated with better cognitive functioning and increased use of cognitive enhancers. The health policy implication is that we need to better engage economically disadvantaged individuals, perhaps at the primary care level.

Entities:  

Mesh:

Year:  2013        PMID: 24331159     DOI: 10.1017/S1041610213002299

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  11 in total

Review 1.  Cognitive reserve and Alzheimer's disease.

Authors:  Wei Xu; Jin-Tai Yu; Meng-Shan Tan; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-05-04       Impact factor: 5.590

Review 2.  The Role of Employment on Neurocognitive Reserve in Adults With HIV: A Review of the Literature.

Authors:  David E Vance; Shameka L Cody; Moka Yoo-Jeong; Gwendolyn Lynn D Jones; William C Nicholson
Journal:  J Assoc Nurses AIDS Care       Date:  2015-04-11       Impact factor: 1.354

3.  Which Stratum of Urban Elderly Is Most Vulnerable for Dementia?

Authors:  Yeonsil Moon; Heeyoung Lee; Ok Kyoung Namgung; Seol Heui Han
Journal:  J Korean Med Sci       Date:  2016-10       Impact factor: 2.153

4.  Family history of Alzheimer's disease alters cognition and is modified by medical and genetic factors.

Authors:  Joshua S Talboom; Asta Håberg; Matthew D De Both; Marcus A Naymik; Isabelle Schrauwen; Candace R Lewis; Stacy F Bertinelli; Callie Hammersland; Mason A Fritz; Amanda J Myers; Meredith Hay; Carol A Barnes; Elizabeth Glisky; Lee Ryan; Matthew J Huentelman
Journal:  Elife       Date:  2019-06-18       Impact factor: 8.140

5.  Parental Education, Household Income, Race, and Children's Working Memory: Complexity of the Effects.

Authors:  Golnoush Akhlaghipour; Shervin Assari
Journal:  Brain Sci       Date:  2020-12-07

6.  Association of Socioeconomic Status With Dementia Diagnosis Among Older Adults in Denmark.

Authors:  Jindong Ding Petersen; Sonja Wehberg; Aake Packness; Nanna Herning Svensson; Nana Hyldig; Søren Raunsgaard; Merethe Kirstine Andersen; Jesper Ryg; Stewart W Mercer; Jens Søndergaard; Frans Boch Waldorff
Journal:  JAMA Netw Open       Date:  2021-05-03

Review 7.  Societal and equity challenges for Brain Health Services. A user manual for Brain Health Services-part 6 of 6.

Authors:  Richard Milne; Daniele Altomare; Federica Ribaldi; José Luis Molinuevo; Giovanni B Frisoni; Carol Brayne
Journal:  Alzheimers Res Ther       Date:  2021-10-11       Impact factor: 6.982

8.  Drug utilization pattern in patients with different types of dementia in Western India.

Authors:  Mansi Patel; Anuradha Joshi; Jalpa Suthar; Soaham Desai
Journal:  Int J Alzheimers Dis       Date:  2014-08-27

9.  Observational cohort study: deprivation and access to anti-dementia drugs in the UK.

Authors:  Claudia Cooper; Rebecca Lodwick; Kate Walters; Rosalind Raine; Jill Manthorpe; Steve Iliffe; Irene Petersen
Journal:  Age Ageing       Date:  2015-11-18       Impact factor: 10.668

10.  Socio-economic status influences access to second-line disease modifying treatment in Relapsing Remitting Multiple Sclerosis patients.

Authors:  Floriane Calocer; Olivier Dejardin; Karine Droulon; Guy Launoy; Gilles Defer
Journal:  PLoS One       Date:  2018-02-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.